Tysabri
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BackgroundNegative news media reports regarding potential health hazards of implanted medical devices and pharmaceuticals can…
Multiple sclerosis (MS) is an immune mediated inflammatory disease that attacks myelinated axons in the central nervous system…
Entyvio (vedolizumab), Takeda’s drug for inflammatory bowel disease (IBD), is in line to become the first integrin inhibitor to…
Therapeutic monoclonal antibodies are potent new tools for a molecular targeted approach to modify the course of multiple…
The US FDA recently approved the monoclonal antibody TYSABRI (natalizumab) for use in the treatment of adults with moderately to…
1061 that isn’t the problem, says ZymoGenetics chief executive Bruce Carter. Rather, it is because the acute hospitals that use…
La Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) ha recibido nueva
informacion de seguridad concerniente al…
The future of a promising treatment for multiple sclerosis (MS) is in question after two patients takinag the drug were diagnosed…
Although the financial implications of Elan's and Biogen Idec's shock withdrawal from the market of the highly promising multiple…